期刊文献+

脂联素和hs-CRP在冠心病患者病情评估中的临床价值 被引量:6

Value of adiponectin and hs-CRP in the evaluation of coranary heart dis-ease's disease condition
下载PDF
导出
摘要 目的研究脂联素和hs-CRP在冠心病患者病情评估中的临床价值。方法根据症状体征将冠心病患者分为稳定型心绞痛组(SAP组)、不稳定型心绞痛组(UAP组)和急性心肌梗死组(AMI组),选择正常健康人为对照(CON组),比较四组研究对象血清脂联素、hs-CRP和Gensini积分的差异,分析脂联素、hs-CRP与Gensini积分相关性。结果 SAP组、UAP组和AMI组冠心病患者脂联素显著低于CON组(P<0.01),hs-CRP和Gensini积分显著高于CON组(P<0.01)。SAP组、UAP组和AMI组脂联素依次降低,hs-CRP和Gensini积分依次升高,差异均具有统计学意义(P<0.01)。SAP组、UAP组和AMI组冠心病患者脂联素与Gensini积分呈负相关(P<0.05),hs-CRP与Gensini积分呈正相关(P<0.05)。结论脂联素和hs-CRP在冠心病患者病情评估中具有重要意义,脂联素水平越低、hs-CRP水平越高,表明冠心病病情越重。 Objective To study the value of adiponectin and hs-CRP in the evaluation of coranary heart disease's disease condition. Methods Adiponectin,hs-CRP and Gensini score were detected in patients with coronary heart dis- ease and healthy people. The differences were compared and the correlation between adiponectin, hs-CRP and Gensi- ni score were analyzed. Results The adiponectin in CON group were significantly higher than in SAP group,UAP group and AMI group,while lower in hs-CRP (P〈0.01). The adiponeetin in SAP group, UAP group and AMI group de- creased successively(P〈0.01 ),while increased in hs-CRP(P〈0.01 ).The adiponeetin correlate negatively with Gensini score in SAP group,UAP group and AMI group,while positively in hs-CRP. Conclusion The serous adiponectin and hs-CRP could be severed as in the evaluation of coranary heart disease's severity. The lower adiponectin and higher hs-CRP indicate more severe disease conditions.
作者 张振业
出处 《中国现代医生》 2013年第31期23-24,共2页 China Modern Doctor
关键词 冠心病 脂联素 hs—CRP 病情评估 Coronary heart disease Adiponectin hs-CRP Evaluation of disease condition
  • 相关文献

参考文献7

二级参考文献62

  • 1裴强,秦永文,吴弘,郑兴,丁继军.血清脂联素水平与冠状动脉病变程度的关系[J].临床心血管病杂志,2004,20(10):619-621. 被引量:33
  • 2陆国平,吴志俊,戚文航.他汀类药物与动脉粥样硬化斑块消退[J].中国循环杂志,2007,22(1):69-72. 被引量:25
  • 3Curat CA, Wegner V, Seugenes C, et al. Macrophages in human visceral adipose tissue : increased accumulation in obesity and a source of resistin and visfatin[ J]. Diabetologia, 2006, 49(4) :744-747.
  • 4Koenig W,Lowel H,Baumert J,et al. C-reactive protein modulates risk prediction based on the Framingham score : implications for future risk assessment : results from a large cohort study in southern Germany [ J]. Circulation ,2004,109 ( 11 ) : 1349-1353.
  • 5Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease [ J ]. Circulation, 2001,103(13) :1813-1818.
  • 6Adya R, Tan BK, Punn A, et al. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways:novel insights into visfatin-induced angiogenesis [ J ]. Cardiovasc Res,2008,78 (2) : 356-365.
  • 7Jones CB, Sane DC, Herrington DM. Matrix metallo- proteinases: a review of their structure and role inacute coronary syndrome [ J ]. Cardiovasc Res,2003, 59(4) :812-823.
  • 8Ouehi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages [ J ]. Circulation,2001,103 (8) : 1057-1063.
  • 9Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipovascular axis [ J ]. J Biol Chem, 2002,277 ( 40 ) : 37487 -37491.
  • 10Ouchi N, Kihara A, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue [ J]. Circulation, 2003,107 (5) : 671-674.

共引文献413

同被引文献61

  • 1王晓蓉.冠心病患者检测同型半胱氨酸以及超敏C反应蛋白的临床价值[J].环球中医药,2013,6(S1):90-91. 被引量:3
  • 2王红霞,牛小媛.颈动脉斑块的稳定性与青中年脑梗死[J].中风与神经疾病杂志,2005,22(2):163-165. 被引量:27
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 4Wei G,Yaqi R,Ningfu W,et al. N-terminal prohormone B- type natriuretic peptide and cardiovascular risk in stable coronary artery disease :a meta-analysis of nine prospec- tive studies [J]. Rev C ardiovasc Med,2013,14 (2-4):92- 98.
  • 5Rajabiani A,Mohaghgheghi A,Kamal-Hedayat D,et al. Does serum N-terminal pro-brain natriuretic peptide level predict the severity of angiographic lesions in patients with acute coronary syndrome? [J]. J Tehran Heart Cent, 2013,8 (3) : 152-157.
  • 6Lu YC ,Hsu CC ,Yu TH,et al. Association between visfatin levels and coronary artery disease in patients with chronic kidney disease [J]. Iran J Kidney Dis,2013,7(6):446-452.
  • 7Chen TH, Lin CL, Shih J J, et al. Plasma B-type natriuret- ic peptide in predicting outcomes of eleetive coronary artery bypass surgery [J]. Kaohsiung J Med Sci ,2013,29 (11):650.
  • 8Baha S,Demir M,Demirkol S,et al. Plasma B-type na- triuretic peptide level in patients with coronary artery bypass surgery [J]. Kaohsiung J Med Sci,2013,29 (11): 648-649.
  • 9Giannitsis E,Spanuth E, I-Iorsch A, et al. High-sensitivi- ty cardiac troponin T and N-terminal pro-B-type natri- uretic peptide predict mortality in stable coronary artery disease:results from the Ludwigshafen risk and cardio- vascular health(LURIC)study [J]. Clin Chem Lab Med, 2013,51 (10) :2019-2028.
  • 10Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA Guide lines for the management of patients with unstable angi- na and non-ST-segment elevation myocardial infarction report of American Collage of Cardiology/American Heart Association task force on practice guidelines[J]. J Am Coll Cardiol, 2000, 36(3):970 1062.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部